Highlights and Quick Summary
- Selling, General and Administrative Expense of Revenue for the quarter ending March 31, 2023 was 2274.07% (a -82.91% decrease compared to previous quarter)
- Year-over-year quarterly Selling, General and Administrative Expense of Revenue increased by Infinity%
- Annual Selling, General and Administrative Expense of Revenue for 2022 was 9104.11% (a 6.27% increase from previous year)
- Annual Selling, General and Administrative Expense of Revenue for 2022 was 8567.12% (a -22.38% decrease from previous year)
- Annual Selling, General and Administrative Expense of Revenue for 2021 was 11037.29% (a 6.96% increase from previous year)
- Twelve month Selling, General and Administrative Expense of Revenue ending March 31, 2023 was 5658.62% (a -26.23% decrease compared to previous quarter)
- Twelve month trailing Selling, General and Administrative Expense of Revenue decreased by -36.14% year-over-year
Trailing Selling, General and Administrative Expense of Revenue for the last four month:
| 31 Mar '23 | 31 Dec '22 | 30 Sep '22 | 30 Jun '22 |
|---|---|---|---|
| 5658.62% | 7670.11% | 0.0% | 8861.33% |
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Selling, General and Administrative Expense of Revenue of Benitec Biopharma Limited
Most recent Selling, General and Administrative Expense of Revenueof BNTC including historical data for past 10 years.Interactive Chart of Selling, General and Administrative Expense of Revenue of Benitec Biopharma Limited
Benitec Biopharma Limited Selling, General and Administrative Expense of Revenue for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 2274.07% | – | – | – | – |
| 2022 | 13307.14% | 0.0% | 0.0% | 2785.42% | 9104.11% |
| 2021 | 6856.0% | 0.0% | 76750.0% | 102900.0% | 11037.29% |
| 2020 | 211100.0% | 3340.0% | -4541.67% | 4596.43% | 5457.84% |
| 2019 | – | – | 2394.81% | 2272.73% | 37.82% |
| 2018 | – | – | – | – | 54.75% |
| 2017 | – | – | – | 79.38% | 26.16% |
| 2016 | – | – | – | 9.8% | 98.1% |
| 2015 | – | – | – | – | 85.67% |
| 2014 | – | – | – | – | 120.42% |
| 2013 | – | – | – | – | 94.57% |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology